Ocugen (OCGN) Times Interest Earned (2014 - 2026)
Ocugen's (OCGN) quarterly Times Interest Earned came in at -$0.98 in Q1 2026, up 91.47% YoY from -$0.51 in Q1 2025, and up 92.28% on a QoQ basis from -$12.76 in Q4 2025.
Powered by 
Analysis
Ocugen (OCGN) Times Interest Earned (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Times Interest Earned data on file, last reported at -$0.98 in Q1 2026.
- Quarterly Times Interest Earned rose 91.47% year-over-year to -$0.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.66 (up 87.78% YoY) and the FY2025 annual result came in at -$0.46, down 1.02% from the prior year.
- Times Interest Earned improved to -$0.98 in Q1 2026, from -$12.76 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.1 in Q4 2023 to a low of -$456.97 in Q3 2024.
- A 5-year average of -$32.21 and a median of -$3.74 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 99.97% — and 2024, when it slumped 22361.42%.
- Tracing OCGN's Times Interest Earned over 5 years: stood at -$0.24 in 2022, then jumped by 57.98% to -$0.1 in 2023, then tumbled by 22361.42% to -$23.03 in 2024, then surged by 44.59% to -$12.76 in 2025, then jumped by 92.28% to -$0.98 in 2026.
- The last three Times Interest Earned figures came in at -$0.98 (Q1 2026), -$12.76 (Q4 2025), and -$13.41 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | -3.67 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.67 |
| Mar 31, 2026 | -13.51 |
| Dec 31, 2025 | -12.76 |
| Sep 30, 2025 | -13.41 |
| Jun 30, 2025 | -10.74 |
| Mar 31, 2025 | -11.54 |
| Dec 31, 2024 | -23.03 |
| Sep 30, 2024 | -456.97 |
| Dec 31, 2021 | -728.60 |
| Sep 30, 2021 | -567.84 |
| Jun 30, 2021 | -1,280.50 |
| Mar 31, 2021 | -352.85 |
| Dec 31, 2020 | -22.94 |
| Sep 30, 2020 | -34.87 |
| Jun 30, 2020 | -13.57 |
| Mar 31, 2020 | -261.93 |
| Dec 31, 2019 | -288.62 |
| Sep 30, 2019 | -3.41 |
| Jun 30, 2019 | -8.90 |
| Mar 31, 2019 | -6.96 |